Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Non-cash Items (2021 - 2025)

Lucid Diagnostics (LUCD) has disclosed Non-cash Items for 5 consecutive years, with $307000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Non-cash Items rose 55.84% year-over-year to $307000.0, compared with a TTM value of $307000.0 through Sep 2025, up 55.84%, and an annual FY2024 reading of $199000.0, down 73.99% over the prior year.
  • Non-cash Items was $307000.0 for Q3 2025 at Lucid Diagnostics, down from $446000.0 in the prior quarter.
  • Across five years, Non-cash Items topped out at $2.0 million in Q1 2025 and bottomed at $499.0 in Q3 2022.
  • Average Non-cash Items over 5 years is $408702.9, with a median of $253000.0 recorded in 2024.
  • The sharpest move saw Non-cash Items surged 69439.08% in 2023, then plummeted 73.99% in 2024.
  • Year by year, Non-cash Items stood at $6665.0 in 2021, then skyrocketed by 6321.61% to $428000.0 in 2022, then skyrocketed by 78.74% to $765000.0 in 2023, then tumbled by 73.99% to $199000.0 in 2024, then soared by 54.27% to $307000.0 in 2025.
  • Business Quant data shows Non-cash Items for LUCD at $307000.0 in Q3 2025, $446000.0 in Q2 2025, and $2.0 million in Q1 2025.